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Abstract
Background: Hypertonic saline (HTS) reduces the severity of lung injury in ischemia-reperfusion,
endotoxin-induced and ventilation-induced lung injury. However, the potential for HTS to
modulate the resolution of lung injury is not known. We investigated the potential for hypertonic
saline to modulate the evolution and resolution of oleic acid induced lung injury.
Methods: Adult male Sprague Dawley rats were used in all experiments. Series 1 examined the
potential for HTS to reduce the severity of evolving oleic acid (OA) induced acute lung injury.
Following intravenous OA administration, animals were randomized to receive isotonic (Control,
n = 12) or hypertonic saline (HTS, n = 12), and the extent of lung injury assessed after 6 hours.
Series 2 examined the potential for HTS to enhance the resolution of oleic acid (OA) induced acute
lung injury. Following intravenous OA administration, animals were randomized to receive isotonic
(Control, n = 6) or hypertonic saline (HTS, n = 6), and the extent of lung injury assessed after 6
hours.
Results: In Series I, HTS significantly reduced bronchoalveolar lavage (BAL) neutrophil count
compared to Control [61.5 ± 9.08 versus 102.6 ± 11.89 × 103 cells.ml-1]. However, there were no
between group differences with regard to: A-a O2 gradient [11.9 ± 0.5 vs. 12.0 ± 0.5 KPa]; arterial
PO2; static lung compliance, or histologic injury. In contrast, in Series 2, hypertonic saline
significantly reduced histologic injury and reduced BAL neutrophil count [24.5 ± 5.9 versus 46.8 ±
4.4 × 103 cells.ml-1], and interleukin-6 levels [681.9 ± 190.4 versus 1365.7 ± 246.8 pg.ml-1].
Conclusion: These findings demonstrate, for the first time, the potential for HTS to reduce
pulmonary inflammation and enhance the resolution of oleic acid induced lung injury.
Background
Hypertonic saline (7.5% saline, HTS) exhibits considera-
ble potential as a therapeutic agent in diverse injury mod-
els. HTS has been demonstrated to inhibit acute lung
injury (ALI) induced by systemic ischemia-reperfusion
[1], hemorrhagic shock [2], and acute pancreatitis [3,4] in
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experimental models. The mechanisms of action of hyper-
tonic saline are increasingly well understood, and include
inhibition of neutrophil adhesion molecule CD11b [5],
reduced TNF-α and IL- l production [1], and reduced acti-
vation of MAP kinase p38 and ERK-1 [6]. Pulmonary neu-
trophil sequestration, which is central to the mechanism
of injury in ALI, is attenuated by HTS in diverse ALI mod-
els [1-3,7]. The therapeutic potential of HTS is demon-
strated by its efficacy when used following initiation of
the injury process, in both ischemia-reperfusion and pan-
creatitis induced ALI [1,3]. HTS has also demonstrated
efficacy in clinical human trials, in patients with post-trau-
matic cerebral oedema [7].
Oleic acid induced lung injury is a well characterized and
clinically relevant model of ALI/ARDS [8-12]. In particu-
lar, it constitutes an excellent model of Fat Embolism Syn-
drome (FES) induced ALI [13], given that OA is a major
component of the marrow-derived fat emboli released
into the circulation following traumatic bone injury
[14,15]. Oleic acid produced a rapidly evolving lung
injury [10], which features increased capillary permeabil-
ity induced pulmonary edema [10] and alveolar infiltra-
tion of inflammatory cells [16]. The ALI produced by OA
is relatively transient, and resolves over several hours [10].
This model therefore permits an evaluation of the thera-
peutic potential of HTS during both the injury and resolu-
tion phases of ALI [10].
The potential for HTS to modulate the resolution of lung
injury is not known. We investigated the potential for
hypertonic saline to modulate the evolution and resolu-
tion of oleic acid induced lung injury. Specifically, we
hypothesized that HTS would modulate the severity of OA
induced ALI, reducing lung injury and/or enhancing reso-
lution of ALI. We used this model to determine the thera-
peutic potential of hypertonic saline in both evolving
(Series 1) and resolving (Series 2) ALI.
Methods
All experimental work was reviewed and approved by the
Research Ethics Committee at the National University of
Ireland, Galway and conducted under license from the
Department of Health and Children, Dublin, Ireland.
Animal Care
Specific pathogen free adult male Sprague Dawley rats
(B&K Universal Ltd., U.K.) weighing 300 to 380 g were
used in all experiments. Animals were housed for a mini-
mum of 7 days prior to study, under controlled light/dark
conditions where the light period was from 8:00 a.m. to
8:00 p.m. They were allowed access to ordinary rat chow
and tap water ad libitum. Animals were maintained at con-
stant ambient temperature of 21–22°C, while the humid-
ity level was maintained between 45% and 55%.
Fat Embolism Syndrome Model
The experimental model was based on that previously
reported, with several modifications [8-12]. Briefly,
anesthesia was induced and maintained with Isoflurane
(Abbott Laboratories, UK). After confirming depth of
anesthesia by absence of response to paw compression, a
tail vein was cannulated using a 24 gauge cannula (Becton
Dickinson, NJ). Oleic acid (OA) (Sigma-Aldrich, United
Kingdom), which was prepared as a 1:1 mixture with pure
ethanol [17], was administered intravenously. Animals
were then randomized to hypertonic saline (HTS) or con-
trol groups. The HTS group were then administered 4
ml.Kg-1 of 7.5% hypertonic saline and the control animals
administered an equal volume of 0.9% saline. The ani-
mals were then allowed to recover from anesthesia, and
then placed in their cages.
Preliminary Studies
Two preliminary series of experiments was carried out to
determine the dose of OA and duration of time required
to produce a significant evolving ALI, and to produce a
model of resolving lung injury. A dose of 40 μl of OA was
determined to produce a significant early lung injury over
a 4 h period. In later studies, a dose of 9 μl per 100 g body
weight was found to produce a lung injury of similar mag-
nitude at 4 hours, and which was resolving at 6 hours fol-
lowing OA administration.
Series I – Evolving ALI
This series was carried out to determine the potential for
HTS to attenuate evolving OA-induced injury. Following
induction of anesthesia, 40 μl of OA was administered
and each rat allowed to recover. Four hours following OA
administration, the animals were re-anesthetized and the
degree of ALI quantified.
Series II – Resolving ALI
This series was carried out to determine whether HTS
could modulate the resolution of OA-induced injury. Fol-
lowing induction of anesthesia, 9 μl.100 g-1 body weight
of OA was administered and each rat was allowed to
recover. Six hours following OA administration, the ani-
mals were re-anesthetized and the extent of lung injury
quantified.
Assessment of Lung Injury
At four (Series I) or six (Series II) hours following OA
administration, the animals were re-anesthetized with
Isoflurane. After confirming depth of anesthesia by
absence of response to paw compression, the dorsal
penile vein and carotid artery were cannulated using 22G
cannulae (Becton Dickinson, NJ). A tracheotomy was per-
formed, and a tracheal tube was inserted to a depth of 2
cm and secured in place. Pancuronium (1 mg; Organon,
The Netherlands) was administered intravenously and theBMC Pulmonary Medicine 2008, 8:9 http://www.biomedcentral.com/1471-2466/8/9
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lungs were then ventilated using a small animal ventilator
(Model 683; Harvard Apparatus, United Kingdom) with a
fractional inspired O2 (FiO2) of 0.21 (room air), respira-
tory rate 90 min.-1, tidal volume 4.5 ml.kg-1 and 2 cm H2O
positive end-expiratory pressure (PEEP).
Systemic arterial pressure, peak airway pressures and tem-
perature were measured throughout the protocol. Arterial
blood samples then were drawn for assessment of sys-
temic oxygenation, ventilation and acid-base status (ABL
710, Radiometer, United Kingdom). Static inflation lung
compliance was measured immediately prior to a recruit-
ment manoeuvre, ensuring a standardized lung volume
history. Incremental 1 ml volumes of room air were
injected via the tracheal cannula, and the pressure
attained 3 seconds after each injection was measured,
until a total volume of 5 ml was injected. At the end of the
protocol, the inspired gas was altered to FiO2 of 1.0 for 5
minutes, and an arterial blood sample was then taken for
calculation of alveolar-arterial oxygen gradient. The ani-
mals were then euthanized by exsanguination under
anesthesia.
Sampling and Assay Protocol
Immediately post mortem, the heart-lung block was dis-
sected from the thorax and bronchoalveolar lavage (BAL)
performed. BAL was carried out by intratracheal instilla-
tion of 3 aliquots (5 ml each) of isotonic saline and col-
lection of the returned fluid by free drainage. Total cell
numbers per ml in BAL fluid were counted and differen-
tial cell counts were performed following staining with
Diff-Quik (BDH, United Kingdom). Samples of BAL fluid
were centrifuged, snap frozen in liquid N2 and stored at -
80°C. The concentration of interleukin-6 (IL-6) in these
BAL samples was determined using quantitative sandwich
ELISA's (R&D Systems, United Kingdom). The BAL pro-
tein concentration was determined using a standard assay
(Biorad Assay, Biorad, Hercules, CA).
The left lung was isolated and fixed with 4% paraformal-
dehyde [18,19], and the extent of histologic lung damage
determined using quantitative stereological techniques as
previously described [20].
Statistical Analysis
Results are expressed as mean ± (SEM) for normally dis-
tributed data, and as median (interquartile range, IQR) if
non-normally distributed. Data were analyzed by one-
way ANOVA followed by Student-Newman-Keuls, t-test
or Kruskalis-Wallis followed by Mann-Whitney U test
with the Bonferroni correction for multiple comparisons,
as appropriate. P < 0.05 was considered statistically signif-
icant.
Results
Series 1 – Evolving OA induced ALI
12 animals were entered into this study. All animals
entered into the study survived the full duration of the
protocol.
Physiologic Indices of Lung Damage
There was no difference between the groups with regard to
arterial oxygen tension, or alveolar-arterial gradient at
21% or 100% oxygen [Table 1]. There was no difference
in peak airway pressures or in static lung compliance
between the groups [Table 1].
Table 1: Data for evolving ALI series
Variable Hypertonic Saline (n = 6) Control (n = 6)
Animal Weight (g) 354 ± 10.0 336 ± 5.3
Mean Arterial Pressure (mmHg)
0 min 144 ± 12.0 140 ± 7.4
10 min 167 ± 7.4 149 ± 7.6
20 min 158 ± 8.7 148 ± 7.8
Peak Airway Pressure (mmHg)
0 min 5.4 ± 0.6 5.7 ± 0.2
10 min 5.3 ± 0.5 5.7 ± 0.2
20 min 6.1 ± 0.6 6.5 ± 0.2
Arterial PO2
FiO2 0.3 11.9 ± 0.5 12.0 ± 0.5
FiO2 1.0 72.0 ± 1.5 71.7 ± 2.1
Alveolar-arterial O2 Gradient (mmHg)
FiO2 = 0.21 11.9 ± 1.00 10.9 ± 0.56
FiO2 = 1.0 21.8 ± 4.94 17.3 ± 2.25
Static Lung Compliance (ml.mmHg-1) 0.43 ± 0.02 0.44 ± 0.02
BAL Protein concentration (mg/L) 4559 ± 418 5398 ± 522
Notes: Data are expressed as mean ± SEM.
*Significantly different from Hypertonic Saline (P < 0.02, ANOVA).BMC Pulmonary Medicine 2008, 8:9 http://www.biomedcentral.com/1471-2466/8/9
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Lung Damage and Inflammation
HTS significantly reduced BAL neutrophil counts com-
pared to control conditions [Figure 1]. BAL IL-6 [Figure 2],
and BAL protein levels [Table 1] were reduced with HTS,
although these differences were not statistically significant
[Figure 3]. However, there was no between group differ-
ence in the degree of histologic injury. Quantitative stere-
ological analysis demonstrated that there was no
significant difference between HTS and Control in regard
to the amount of tissue or airspace in the gas exchanging
portion of the lung.
Series 2 – Resolving OA induced ALI
24 animals were entered into this study. All animals
entered into the study survived the full duration of the
protocol.
Physiologic indices of Lung Damage
There was no difference between the groups with regard to
arterial oxygen tension, or alveolar-arterial gradient at
21% or 100% oxygen [Table 2]. There was no difference
in peak airway pressures or in static lung compliance
between the groups [Table 2].
Lung Damage and Inflammation
HTS significantly reduced BAL neutrophil counts [Figure
4], and BAL IL-6 concentrations [Figure 5] compared to
control conditions. BAL protein levels were reduced with
HTS, although these differences were not statistically sig-
nificant [Table 2]. HTS significantly reduced the degree of
histologic injury compared to isotonic saline [Figure 6].
Quantitative stereological analysis demonstrated that HTS
significantly increased alveolar airspace, and significantly
reduced alveolar tissue, indicating reduced histologic lung
damage, compared to control conditions.
Discussion
We demonstrate for the first time the potential for hyper-
tonic saline to modulate the resolution of acute lung
injury. Hypertonic saline reduced alveolar neutrophil
infiltration in both evolving and resolving oleic induced
ALI. Of perhaps greater significance, HTS enhanced the
Histogram representing stereologic assessment of the extent  of histologic injury in evolving oleic acid induced ALI Figure 3
Histogram representing stereologic assessment of 
the extent of histologic injury in evolving oleic acid 
induced ALI. The abbreviations used are as follows: HTS, 
hypertonic saline.
Histogram representing number of neutrophils per mililitre  of bronchoalveolar lavage fluid in evolving oleic acid induced  ALI Figure 1
Histogram representing number of neutrophils per 
mililitre of bronchoalveolar lavage fluid in evolving 
oleic acid induced ALI. The abbreviations used are as fol-
lows: HTS, hypertonic saline; BAL, bronchoalveolar lavage. * 
Significantly different compared to control (P < 0.05, t test).
Histogram representing the bronchoalveolar lavage inter- leukin 6 concentrations in evolving oleic acid induced ALI Figure 2
Histogram representing the bronchoalveolar lavage 
interleukin 6 concentrations in evolving oleic acid 
induced ALI. The abbreviations used are as follows: HTS, 
hypertonic saline; BAL, bronchoalveolar lavage.BMC Pulmonary Medicine 2008, 8:9 http://www.biomedcentral.com/1471-2466/8/9
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resolution of OA induced lung injury, as evidenced by a
reduced severity of histologic injury, and reduced indices
of inflammation, compared to control conditions.
HTS – Therapeutic Potential in ALI
The neutrophil-endothelial cell interaction is central to
the pathogenesis of ALI/ARDS. HTS is a potent inhibitor
of neutrophil function, downregulating neutrophil oxida-
tive burst activity [21], reducing neutrophil adhesion mol-
ecule expression [22] and suppressing neutrophil
activation and the release of pro-inflammatory cytokines
[5,23]. HTS decreased lung neutrophil infiltration [24,25]
and ICAM-1 [25] expression in the setting of hemorrhagic
shock.
HTS has been demonstrated to reduce pulmonary edema,
histologic injury, and lung neutrophil infiltration follow-
ing systemic ischemia-reperfusion injury [1]. HTS also
reduced serum IL-6 and TNF-α cytokine levels in this
Histogram representing the bronchoalveolar lavage inter- leukin 6 concentrations in evolving oleic acid induced ALI Figure 5
Histogram representing the bronchoalveolar lavage 
interleukin 6 concentrations in evolving oleic acid 
induced ALI. The abbreviations used are as follows: HTS, 
hypertonic saline; BAL, bronchoalveolar lavage. * Significantly 
different compared to control (P < 0.05, t test).
Table 2: Data for resolving ALI series
Variable Hypertonic Saline (n = 12) Control (n = 12)
Animal Weight (g) 330 ± 6.5 334 ± 5.5
Mean Arterial Pressure (mmHg)
0 min 141 ± 9.0 119 ± 8.9
10 min 160 ± 7.3 150 ± 5.8
20 min 150 ± 7.8 142 ± 7.5
Peak Airway Pressure (mmHg)
0 min 4.8 ± 0.3 5.2 ± 0.2
10 min 4.7 ± 0.3 4.9 ± 0.1
20 min 5.1 ± 0.3 5.3 ± 0.2
Arterial PO2
FiO2 0.3 12.2 ± 0.6 11.9 ± 0.6
FiO2 1.0 71.0 ± 0.9 68.3 ± 2.0
Alveolar-arterial O2 Gradient (mmHg)
FiO2 = 0.21 10.8 ± 0.5 11.0 ± 0.6
FiO2 = 1.0 18.7 ± 0.9 22.0 ± 2.0
Static Lung Compliance (ml.mmHg-1) 0.55 ± 0.04 0.44 ± 0.04
BAL Protein concentration (mg/L) 2595 ± 640 3888 ± 564
Data are expressed as mean ± SEM.
*Significantly different from Hypertonic Saline (P < 0.05, ANOVA).
Histogram representing number of neutrophils per mililitre  of bronchoalveolar lavage fluid in resolving oleic acid induced  ALI Figure 4
Histogram representing number of neutrophils per 
mililitre of bronchoalveolar lavage fluid in resolving 
oleic acid induced ALI. The abbreviations used are as fol-
lows: HTS, hypertonic saline; BAL, bronchoalveolar lavage. * 
Significantly different compared to control (P < 0.05, t test).BMC Pulmonary Medicine 2008, 8:9 http://www.biomedcentral.com/1471-2466/8/9
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study. HTS reduced the increase in lung permeability and
lung neutrophil sequestration and activation following
trauma-haemorrhagic shock [26]. HTS resuscitation also
increased survival, and reduced lung injury, in a two-hit
injury model of hemorrhage followed by cecal ligation
and puncture in mice [27]. HTS transiently improved tis-
sue oxygen delivery and increased oxygen consumption in
a canine model of oleic acid-induced lung injury [28].
However, the potential for HTS to modulate oleic acid-
induced ALI has not been assessed
Effect of HTS on evolving ALI
HTS did not reduce the severity of evolving oleic acid
induced ALI. There was no difference between HTS and an
equal volume of isotonic saline in terms of arterial oxy-
genation, pulmonary shunt or lung static or dynamic
compliance. The degree of histologic injury on quantita-
tive stereological analysis was similar with HTS versus iso-
tonic saline, with no difference in the amount of tissue or
airspace in the gas exchanging portion of the lung. In con-
trast to these findings, HTS did appear to reduce pulmo-
nary inflammation, significantly reducing
bronchoalveolar lavage neutrophil cell counts, in keeping
with previous findings in hemorrhage-induced ALI mod-
els [22,24,25]. While the bronchoalveolar lavage protein
and interleukin-6 levels showed a clear trend towards
decrease in the HTS group, the results were not statistically
significant. Therefore, while HTS reduced indices of pul-
monary inflammation, it not attenuate the severity of
oleic acid induced ALI.
HTS enhances resolution of ALI
A key feature of the oleic acid model of ALI is the fact that
the injury is transient, permitting study of the effects of
HTS on the resolution of the ALI. HTS did enhance the res-
olution of oleic acid induced ALI. Of importance, the
degree of histologic injury on quantitative stereological
analysis was clearly reduced by HTS. Specifically, there
was a significantly reduced amount of tissue and a signif-
icantly greater amount of airspace in the gas exchanging
portion of the lung. Furthermore, HTS reduced pulmo-
nary inflammation, significantly reducing bronchoalveo-
lar lavage neutrophil cell counts and interleukin-6 levels.
Interestingly, HTS did not modulate physiologic indices
of lung injury, in terms of arterial oxygenation, pulmo-
nary shunt or lung static or dynamic compliance. This
may reflect the fact that different parameters of lung injury
and damage may resolve over differing time courses.
Limitations of findings
Our study has a number of limitations. In particular, it is
not clear whether the effects seen are a function of the
additional saline load, or the hypertonicity per se. We
chose to use a control group of an equal volume of isot-
onic saline in order to compare the effects of equal infu-
sion volumes. Additional studies, which compare the
effects of HTS to an equi-osmolar load of isotonic saline,
are required. The relatively short experimental time
frames studied may have restricted the capacity to fully
characterize the therapeutic potential of HTS, particularly
during the recovery phase. However oleic acid injury is rel-
atively transient and the time points utilized allowed
characterisation of the effects of HTS during injury evolu-
tion and resolution.
Conclusion
In conclusion, we report for the first time that hypertonic
saline enhances the resolution of oleic induced ALI. These
findings further enhance the therapeutic potential of
hypertonic saline in ALI/ARDS.
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